Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Paroxetine-induced increase in LDL cholesterol levels.

Le Melledo JM, Mailo K, Lara N, Abadia MC, Gil L, Van Ameringen M, Baker G, Perez-Parada J.

J Psychopharmacol. 2009 Sep;23(7):826-30. doi: 10.1177/0269881108094320. Epub 2008 Dec 12.

PMID:
19074543
2.

Increased cholesterol levels during paroxetine administration in healthy men.

Lara N, Baker GB, Archer SL, Le Mellédo JM.

J Clin Psychiatry. 2003 Dec;64(12):1455-9.

PMID:
14728107
3.

Increased cholesterol levels after paroxetine treatment in patients with panic disorder.

Kim EJ, Yu BH.

J Clin Psychopharmacol. 2005 Dec;25(6):597-9.

PMID:
16282846
5.

Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.

Herrán A, Ramírez ML, Carrera M, García-Unzueta MT, Sierra-Biddle D, Rodríguez-Cabo B, Ayestarán A, Hoyuela F, Vázquez-Barquero JL.

J Clin Psychopharmacol. 2006 Oct;26(5):538-40. No abstract available.

PMID:
16974205
6.
7.

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.

Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.

PMID:
19101227
8.
9.

National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.

Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG.

Am Heart J. 2008 Aug;156(2):284-91. doi: 10.1016/j.ahj.2008.03.004. Epub 2008 Jun 4.

PMID:
18657658
10.

Paroxetine increases heart rate variability in panic disorder.

Tucker P, Adamson P, Miranda R Jr, Scarborough A, Williams D, Groff J, McLean H.

J Clin Psychopharmacol. 1997 Oct;17(5):370-6.

PMID:
9315988
11.

Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.

Yeragani VK, Pohl R, Jampala VC, Balon R, Ramesh C, Srinivasan K.

Depress Anxiety. 2000;11(3):126-30.

PMID:
10875054
12.

A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.

Nart A, Uslu A, Bozkaya G, Aykas A, Dogan M, Karaca B.

Transplant Proc. 2009 Mar;41(2):751-5. doi: 10.1016/j.transproceed.2009.01.043.

PMID:
19328972
13.

Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.

Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW; L-TAP 2 Investigators.

Am Heart J. 2009 Nov;158(5):860-6. doi: 10.1016/j.ahj.2009.08.009.

PMID:
19853709
14.

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, Hiserote P, Clearfield MB.

Am J Cardiol. 2009 Sep 15;104(6):829-34. doi: 10.1016/j.amjcard.2009.05.020.

PMID:
19733719
15.

Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.

Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):438-44. doi: 10.1097/HJR.0b013e32832a4e25.

PMID:
19369876
16.

Cholesterol and coronary events. The current thinking.

Jones PH.

Postgrad Med. 2003 Apr;113(4 Suppl):5-14. doi: 10.3810/pgm.04.2003.suppl26.135.

PMID:
19667618
17.

beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.

Lee IS, Kim KJ, Kang EH, Yu BH.

J Affect Disord. 2008 Sep;110(1-2):156-60. doi: 10.1016/j.jad.2007.12.007. Epub 2008 Jan 15.

PMID:
18199486
18.

Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.

Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA.

Niger J Clin Pract. 2008 Dec;11(4):330-5.

PMID:
19320405
19.

Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.

Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL; SMART Study Group.

Eur J Clin Invest. 2009 Aug;39(8):680-8. doi: 10.1111/j.1365-2362.2009.02155.x. Epub 2009 May 12.

PMID:
19453647
20.

Supplemental Content

Support Center